Jonathan Brewer is Professor and group leader at the Department of Biochemistry and Molecular Biology at the University of Southern Denmark. He also holds the position of Head of Section for the Bioimaging section and is the Director for the Danish Molecular Biomedical Imaging Center (DaMBIC).
The overall mission of the Brewer Group is to create and characterize new innovative biobased materials to find solutions for societies problems within the fields of health and environment.
The Brewer Group focuses on combining molecular biology with the use of advanced bioimaging techniques to answer fundamental questions in biological systems and is internationally recognized for performing advanced studies in bio-imaging of tissue and biomaterials.
The group has worked extensively with characterization of skin and artificially grown skin and is now developing skin cancer models, 3D tissue bioprinting and a microfluidic-based organ on a chip system, as well as production of artificial spider silk. The group also works with development of novel quantitative bioimaging techniques and are presently developing an image-based method to quantify expression, localization, and spatial organization of RNA in single cells in tissue.
As the Director of the Danish Molecular Biomedical Imaging Center, DaMBIC, Dr. Brewer has developed an imaging facility at a high international standard. DaMBIC hosts several state of the art bioimaging techniques which are unique in Denmark. Dr. Brewer has cofounded the Danish Bioimaging Network, and is an active member of the board. The Brewer Group collaborates with leading companies including Merck, Coloplast, Riemann, Leo Pharma, Chr. Hansen and Arla.
Head of research: Professor, PhD Jonathan R. Brewer
Researchers and research group: Jonathan Brewer Lab
Group webpage: DaMBIC
